October 03, 2024

First Emergency-Use Mpox Diagnostic Test Approved

The WHO has approved the first mpox diagnostic test for emergency use, addressing the need for effective diagnostics, particularly in low-income groups.

Reuters

October 02, 2024

French Study Uncovers EN Mortality, Sequelae Patterns

French study reveals epidermal necrolysis has 34% one-year mortality rate, with postdischarge deaths linked to acute complications rather than initial disease severity.

Conexiant

September 24, 2024

Pediatric Wards: Idaho Bursting, Alaska Empty

From overflowing cribs to empty pediatric wings, new data reveals a 133.3% difference in children's hospital bed occupancy rates between the most and least crowded states.

Conexiant

September 24, 2024

PrEP Use Linked to Higher Gonorrhea Rate

Study reveals PrEP users face 4-fold higher gonorrhea risk, highlighting the need for integrated STI screening in HIV prevention strategies.

Conexiant

September 17, 2024

Is Penicillin Allergy Overdiagnosed? Meta-Analysis Questions Prevalence

Direct penicillin challenges led to reactions in only 3.5% of 9,225 patients across 56 studies, raising doubts about the perceived prevalence of penicillin allergies.

Conexiant

September 11, 2024

Probiotics: A New Ally Against Periodontal Disease?

Probiotics showed promise in reducing clinical attachment loss compared to antibiotics in periodontal disease management, potentially offering a new treatment avenue for dentists.

Conexiant

September 06, 2024

Post-Radiation Dental Extractions Linked to High Risk of Exposed Bone

New study reveals 40% incidence of exposed bone in head and neck cancer patients undergoing dental extractions post-radiation therapy, challenging current treatment paradigms.

Conexiant

September 06, 2024

Beyond the Gums: Blood Markers Betray Periodontitis

Severe periodontitis patients showed 3.85 times lower serum EGF levels, potentially signaling impaired wound healing in this large-scale protein profiling study.

Conexiant

September 06, 2024

US Ramps Up Mpox Response Amid New Strain Concerns

Health officials deploy dual strategy against new mpox strain: ramped-up testing and easy vaccine access at local pharmacies and clinics.

Reuters